QAF Limited (SGX:Q01)
Singapore · Delayed Price · Currency is SGD 0.8650
0.00 (0.00%)
Aug 13, 2025, 4:35 PM SGT
Ligand Pharmaceuticals Cash Flow Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 26.14 | 34.7 | 27.49 | 19.41 | 52.08 | 27.74 | Upgrade |
Depreciation & Amortization | 26.94 | 26.64 | 24.84 | 28.54 | 34.39 | 48.06 | Upgrade |
Other Amortization | 0.02 | 0.02 | 0.02 | 0.01 | - | - | Upgrade |
Loss (Gain) From Sale of Assets | 0.14 | -0.05 | 0.1 | 0.09 | -1.64 | 28.57 | Upgrade |
Asset Writedown & Restructuring Costs | 1.96 | 1.35 | - | - | 3.49 | 1.04 | Upgrade |
Loss (Gain) From Sale of Investments | - | - | 0.04 | - | - | -0.36 | Upgrade |
Loss (Gain) on Equity Investments | -4.6 | -4.73 | 8.37 | -2.72 | -4.22 | -5.56 | Upgrade |
Provision & Write-off of Bad Debts | 0.75 | 0.7 | 0.67 | -0.01 | 0.31 | 5.47 | Upgrade |
Other Operating Activities | 7.34 | 8 | 4.8 | 10.28 | -36.52 | 13.36 | Upgrade |
Change in Accounts Receivable | 9.76 | 8.73 | -16.08 | 5.89 | -13.46 | 10.4 | Upgrade |
Change in Inventory | -2.78 | -8.46 | 4.07 | -5.07 | -0.41 | -11.12 | Upgrade |
Change in Accounts Payable | -0.41 | -1.64 | 3.27 | -1.49 | 32.38 | -12.69 | Upgrade |
Operating Cash Flow | 65.28 | 65.26 | 57.57 | 52.45 | 109.19 | 95.98 | Upgrade |
Operating Cash Flow Growth | 7.19% | 13.35% | 9.78% | -51.97% | 13.76% | 61.64% | Upgrade |
Capital Expenditures | -18.06 | -19.34 | -39.68 | -26.55 | -30.09 | -31.15 | Upgrade |
Sale of Property, Plant & Equipment | 0.14 | 0.3 | 0.4 | 0.21 | 0.33 | 0.42 | Upgrade |
Divestitures | - | - | - | 111.49 | -0.1 | - | Upgrade |
Sale (Purchase) of Intangibles | - | - | -0.02 | -0.03 | -0.03 | -0.06 | Upgrade |
Investment in Securities | - | - | 0.11 | - | - | 1.99 | Upgrade |
Other Investing Activities | 5.88 | 5.88 | 5.77 | 9.25 | 6.47 | 9.85 | Upgrade |
Investing Cash Flow | -12.04 | -13.15 | -33.42 | 94.37 | -23.41 | -18.94 | Upgrade |
Long-Term Debt Issued | - | 1.19 | 17.67 | 0.23 | 0.29 | 15.26 | Upgrade |
Long-Term Debt Repaid | - | -23.38 | -11.71 | -12.71 | -43.92 | -19.56 | Upgrade |
Total Debt Repaid | -18.29 | -23.38 | -11.71 | -12.71 | -43.92 | -19.56 | Upgrade |
Net Debt Issued (Repaid) | -17.11 | -22.19 | 5.96 | -12.48 | -43.63 | -4.3 | Upgrade |
Common Dividends Paid | -28.76 | -28.76 | -28.76 | -28.76 | -28.76 | -28.76 | Upgrade |
Other Financing Activities | 0.25 | 0.25 | -0.16 | -0.2 | -0.29 | -0.33 | Upgrade |
Financing Cash Flow | -45.62 | -50.7 | -22.96 | -52.95 | -72.68 | -33.39 | Upgrade |
Foreign Exchange Rate Adjustments | -9.51 | -7.67 | -2.31 | -7.57 | -2.72 | 3.29 | Upgrade |
Net Cash Flow | -1.89 | -6.27 | -1.12 | 86.3 | 10.38 | 46.94 | Upgrade |
Free Cash Flow | 47.21 | 45.92 | 17.89 | 25.89 | 79.1 | 64.83 | Upgrade |
Free Cash Flow Growth | 34.34% | 156.63% | -30.90% | -67.27% | 22.01% | 171.17% | Upgrade |
Free Cash Flow Margin | 7.46% | 7.22% | 2.85% | 4.48% | 14.15% | 11.54% | Upgrade |
Free Cash Flow Per Share | - | 0.08 | 0.03 | 0.04 | 0.14 | 0.11 | Upgrade |
Cash Interest Paid | 2.07 | 2.07 | 2.08 | 1.67 | 3.62 | 4.64 | Upgrade |
Cash Income Tax Paid | 10.65 | 10.65 | 10.22 | 12.4 | 13.2 | 9.45 | Upgrade |
Levered Free Cash Flow | 34.75 | 29.56 | -0.58 | 158.34 | 3.99 | -13.57 | Upgrade |
Unlevered Free Cash Flow | 35.76 | 30.82 | 0.72 | 159.38 | 5.21 | -11.96 | Upgrade |
Change in Working Capital | 6.58 | -1.37 | -8.74 | -0.67 | 18.51 | -13.41 | Upgrade |
Updated Aug 8, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.